Literature DB >> 15331316

Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure.

Joseph L Izzo1, Alan H Gradman.   

Abstract

Hypertensive heart disease (HHD) is a spectrum of abnormalities that represents the accumulation of a lifetime of functional and structural adaptations to increased blood pressure load. Left ventricular hypertrophy (LVH), increasing vascular and ventricular stiffness,and diastolic dysfunction are prominent intermediate features of this syndrome that operate in parallel with ischemic heart disease and ultimately cause heart failure (HF) if inadequately treated. Outcomes in HHD and HF are improved by antihypertensive drugs at any stage of the condition. This review describes an integrated model of the natural history, pathogenesis, and drug treatment of hypertensive heart disease that is consistent with the recommendations of the Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, including an important modification to the HF guideline published by the American College of Cardiology and the American Heart Association that includes LVH and diastolic dysfunction as treatable conditions within the HHD-HF continuum.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331316     DOI: 10.1016/j.mcna.2004.06.002

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  22 in total

Review 1.  Evidence for aggressive blood pressure-lowering goals in patients with coronary artery disease.

Authors:  Monisankar Roy; Noman Mahmood; Clive Rosendorff
Journal:  Curr Atheroscler Rep       Date:  2010-03       Impact factor: 5.113

Review 2.  Losartan: a review of its use in stroke risk reduction in patients with hypertension and left ventricular hypertrophy.

Authors:  Marit D Moen; Antona J Wagstaff
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Predicting changes in hypertension control using electronic health records from a chronic disease management program.

Authors:  Jimeng Sun; Candace D McNaughton; Ping Zhang; Adam Perer; Aris Gkoulalas-Divanis; Joshua C Denny; Jacqueline Kirby; Thomas Lasko; Alexander Saip; Bradley A Malin
Journal:  J Am Med Inform Assoc       Date:  2013-09-17       Impact factor: 4.497

4.  The effect of left ventricular remodelling on soluble ST2 in a cohort of hypertensive subjects.

Authors:  D B Ojji; L H Opie; S Lecour; L Lacerda; O M Adeyemi; K Sliwa
Journal:  J Hum Hypertens       Date:  2014-01-09       Impact factor: 3.012

Review 5.  Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.

Authors:  Min-Seok Kim; Ju-Hee Lee; Eung Ju Kim; Dae-Gyun Park; Sung-Ji Park; Jin Joo Park; Mi-Seung Shin; Byung Su Yoo; Jong-Chan Youn; Sang Eun Lee; Sang Hyun Ihm; Se Yong Jang; Sang-Ho Jo; Jae Yeong Cho; Hyun-Jai Cho; Seonghoon Choi; Jin-Oh Choi; Seong Woo Han; Kyung Kuk Hwang; Eun Seok Jeon; Myeong-Chan Cho; Shung Chull Chae; Dong-Ju Choi
Journal:  Korean Circ J       Date:  2017-09-18       Impact factor: 3.243

6.  Case 2/2017 - 56-Year-Old Male with Refractory Heart Failure, Systemic Arterial Hypertension and Aortic Valve Stenosis That Led to Heart Transplantation.

Authors:  Desidério Favarato; Paulo Sampaio Gutierrez
Journal:  Arq Bras Cardiol       Date:  2017-05       Impact factor: 2.000

7.  Neurocardiological differences between musicians and control subjects.

Authors:  J L I Burggraaf; T W Elffers; F M Segeth; F M C Austie; M B Plug; M G J Gademan; A C Maan; S Man; M de Muynck; T Soekkha; A Simonsz; E E van der Wall; M J Schalij; C A Swenne
Journal:  Neth Heart J       Date:  2013-04       Impact factor: 2.380

Review 8.  Circulating biomarkers in the early detection of hypertensive heart disease: usefulness in the developing world.

Authors:  Dike Ojji; Elena Libhaber; Kim Lamont; Friedrich Thienemann; Karen Sliwa
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

9.  Estrogen delays the progression of salt-induced cardiac hypertrophy by influencing the renin-angiotensin system in heterozygous proANP gene-disrupted mice.

Authors:  S Jeson Sangaralingham; M Yat Tse; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2007-08-23       Impact factor: 3.396

Review 10.  Plasma cardiotrophin-1 levels are associated with hypertensive heart disease: a meta-analysis.

Authors:  Kangxing Song; Shuxia Wang; Bihui Huang; Amelia Luciano; Roshni Srivastava; Arya Mani
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-07-23       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.